Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

A Look Into Healthcare Sector Value Stocks

Author: Benzinga Insights | March 11, 2024 10:43am

Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the healthcare sector:

  1. Kiora Pharmaceuticals (NASDAQ:KPRX) - P/E: 0.84
  2. Procaps Gr (NASDAQ:PROC) - P/E: 6.16
  3. InMode (NASDAQ:INMD) - P/E: 9.55
  4. Alkermes (NASDAQ:ALKS) - P/E: 9.56
  5. Syros Pharmaceuticals (NASDAQ:SYRS) - P/E: 7.97

Kiora Pharmaceuticals saw a decrease in earnings per share from -0.79 in Q2 to $-0.89 now. Procaps Gr saw a decrease in earnings per share from 0.27 in Q2 to $0.08 now. Most recently, InMode reported earnings per share at $0.71, whereas in Q3 earnings per share sat at $0.61. Alkermes's earnings per share for Q4 sits at $0.48, whereas in Q3, they were at 0.64. This quarter, Syros Pharmaceuticals experienced a decrease in earnings per share, which was $-1.3 in Q2 and is now $-1.43.

The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.

Posted In: ALKS INMD KPRX PROC SYRS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist